Departments of Pathology, Emory University Hospital, Atlanta, GA, USA.
Am J Surg Pathol. 2010 Oct;34(10):1417-24. doi: 10.1097/PAS.0b013e3181f0b05a.
Prognostication of invasive ampullary adenocarcinomas (AACs) and their stratification into appropriate management categories have been highly challenging owing to a lack of well-established predictive parameters. In colorectal cancers, recent studies have shown that tumor budding confers a worse prognosis and correlates significantly with nodal metastasis and recurrence; however, this has not been evaluated in AAC.To investigate the prevalence, significance, and clinical correlations of tumor budding in AAC, 244 surgically resected, stringently defined, invasive AAC were analyzed for tumor budding---defined as the presence of more than or equal to 5 isolated single cancer cells or clusters composed of fewer than 5 cancer cells per field measuring 0.785 mm using a 20× objective lens in the stroma of the invasive front. The extent of the budding was then further classified as "high" if there were greater than or equal to 3 budding foci and as "low" if there were <3 budding foci or no budding focus.One hundred ninety-four AACs (80%) were found to be high-budding and 50 (20%) were low-budding. When the clinicopathologic features and survival of the 2 groups were compared, the AACs with high-budding had larger invasion size (19 mm vs. 13 mm; P<0.001), an unrecognizable/absent preinvasive component (57% vs. 82%; P<0.005), infiltrative growth (51% vs. 2%; P<0.001), nonintestinal-type histology (72% vs. 46%; P<0.001), worse differentiation (58% vs. 10%; P<0.001), more lymphatic (74% vs. 10%; P<0.001), and perineural invasion (28% vs. 2%; P<0.001); more lymph node metastasis (44% vs. 17%; P<0.001), higher T-stage (T3 and T4) (42% vs. 10%; P<0.001), and more aggressive behavior (mean survival: 50 mo vs. 32 mo; 3-year and 5-year survival rates: 93% vs. 41% and 68% vs. 24%, respectively; P<0.001). Furthermore, using a multivariable Cox regression model, tumor budding was found to be an independent predictor of survival (P=0.01), which impacts prognosis (hazard ratio: 2.6) even more than T-stage and lymph node metastasis (hazard ratio: 1.9 and 1.8, respectively).In conclusion, tumor budding is frequently encountered in AAC. High-budding is a strong independent predictor of overall survival, with a prognostic correlation stronger than the 2 established parameters: T-stage and lymph node metastasis. Therefore, budding should be incorporated into surgical pathology reports for AAC.
预测侵袭性壶腹腺癌 (AAC) 并将其分层为适当的管理类别一直极具挑战性,因为缺乏成熟的预测参数。在结直肠癌中,最近的研究表明肿瘤芽殖预示着更差的预后,并与淋巴结转移和复发显著相关;然而,这在 AAC 中尚未得到评估。为了研究肿瘤芽殖在 AAC 中的流行率、意义和临床相关性,对 244 例经严格定义的侵袭性 AAC 进行了肿瘤芽殖分析——定义为在侵袭前沿的基质中存在超过或等于 5 个孤立的单个癌细胞或由少于 5 个癌细胞组成的簇,每个簇的直径为 0.785mm,使用 20×物镜。然后,如果存在大于或等于 3 个芽殖焦点,则将芽殖程度进一步分类为“高”,如果存在 <3 个芽殖焦点或没有芽殖焦点,则将其分类为“低”。结果发现 194 例 AAC(80%)为高芽殖,50 例(20%)为低芽殖。当比较两组的临床病理特征和生存情况时,高芽殖 AAC 的侵袭性更大(19mm 比 13mm;P<0.001),无/缺失不可识别的前浸润成分(57%比 82%;P<0.005),浸润性生长(51%比 2%;P<0.001),非肠型组织学(72%比 46%;P<0.001),分化较差(58%比 10%;P<0.001),淋巴管浸润更多(74%比 10%;P<0.001),神经周围浸润更多(28%比 2%;P<0.001);淋巴结转移更多(44%比 17%;P<0.001),更高的 T 分期(T3 和 T4)(42%比 10%;P<0.001),侵袭性行为更具侵袭性(平均生存:50mo 比 32mo;3 年和 5 年生存率:93%比 41%和 68%比 24%;P<0.001)。此外,使用多变量 Cox 回归模型,肿瘤芽殖被发现是生存的独立预测因子(P=0.01),其预后影响(风险比:2.6)甚至比 T 分期和淋巴结转移(风险比:1.9 和 1.8)更显著。总之,肿瘤芽殖在 AAC 中经常发生。高芽殖是总生存的一个强有力的独立预测因子,其预后相关性强于 2 个已确立的参数:T 分期和淋巴结转移。因此,芽殖应该被纳入 AAC 的外科病理报告中。
Am J Surg Pathol. 2010-10
J Surg Oncol. 2011-8-31
Eur J Surg Oncol. 1990-6
Ann Gastroenterol Surg. 2022-7-30
Indian J Otolaryngol Head Neck Surg. 2022-12
J Gastrointest Surg. 2021-7
Chirurgia (Bucur). 2009
Ann Surg Oncol. 2010-1-28
Colorectal Dis. 2011-3
Am J Surg Pathol. 2009-1